Clearline Capital’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-144,187
| Closed | -$411K | – | 133 |
|
|
2024
Q3 | $411K | Sell |
144,187
-19,886
| -12% | -$56.7K | 0.02% | 131 |
|
|
2024
Q2 | $384K | Sell |
164,073
-4,911
| -3% | -$11.5K | 0.01% | 133 |
|
|
2024
Q1 | $497K | Sell |
168,984
-65,712
| -28% | -$193K | 0.02% | 111 |
|
|
2023
Q4 | $702K | Sell |
234,696
-30,207
| -11% | -$90.3K | 0.04% | 86 |
|
|
2023
Q3 | $837K | Hold |
264,903
| – | – | 0.07% | 106 |
|
|
2023
Q2 | $1.03M | Hold |
264,903
| – | – | 0.06% | 88 |
|
|
2023
Q1 | $734K | Hold |
264,903
| – | – | 0.11% | 82 |
|
|
2022
Q4 | $477K | Hold |
264,903
| – | – | 0.09% | 102 |
|
|
2022
Q3 | $562K | Buy |
264,903
+2,543
| +1% | +$5.4K | 0.07% | 114 |
|
|
2022
Q2 | $706K | Buy |
262,360
+15,647
| +6% | +$42.1K | 0.09% | 102 |
|
|
2022
Q1 | $1.07M | Buy |
246,713
+18,188
| +8% | +$79K | 0.12% | 89 |
|
|
2021
Q4 | $1.18M | Buy |
228,525
+69,395
| +44% | +$360K | 0.13% | 86 |
|
|
2021
Q3 | $977K | Buy |
159,130
+118,018
| +287% | +$725K | 0.09% | 101 |
|
|
2021
Q2 | $415K | Buy |
+41,112
| New | +$415K | 0.06% | 120 |
|